ANI Pharmaceuticals (ANIP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Most readers would already be aware that ANI Pharmaceuticals' (NASDAQ:ANIP) stock increased significantly by 17% over...
Acadia's (ACAD) earnings in the first quarter of 2024 beat the Zacks Consensus Estimate, while revenues miss the same.